ClinicalTrials.gg
Not yet recruitingNCT07890363Updated Oct 22, 2026

Gamified Home-Based Core Neuromuscular Training for Chronic Low Back Pain

An interventional study of Gamified Intervention Group: core neuromuscular exercise program using a digital application with gamification features and Non-Gamified Control Group in Low Back Pain and Low Back Pain and Core Muscle, sponsored by Princess Nourah Bint Abdulrahman University. Not yet recruiting. Open to female participants aged 18 Years to 45 Years. Per ClinicalTrials.gov, last updated 2026-10-22.

Sponsored by Princess Nourah Bint Abdulrahman University · Not applicable, Interventional, and Treatment

Updated Oct 22, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years to 45 Years
Sex
Female
01

Study summary

This randomized controlled trial aims to evaluate the effects of gamified home-based core neuromuscular training on pain intensity, functional disability, core muscular endurance, and exercise adherence in women with chronic nonspecific low back pain. Participants will be randomly allocated in a 1:1 ratio to either a gamified intervention group or a non-gamified control group. Both groups will perform the same progressive core exercise program. The intervention group will use a digital application with gamification features, while the control group will perform the exercises without gamification. Outcomes will be assessed at baseline, week 3, and week 6. The study will determine whether gamification provides additional benefits over conventional home-based exercise in improving clinical outcomes and exercise adherence in women with chronic nonspecific low back pain.

Read the detailed description

Chronic nonspecific low back pain is associated with persistent pain and functional disability. Although home-based core exercises are commonly used in rehabilitation, maintaining exercise adherence can be challenging. Gamification may enhance motivation and engagement through interactive digital features.

This randomized controlled trial will recruit women aged 18-45 years with chronic nonspecific low back pain lasting at least 12 weeks and a baseline moderate pain intensity or more. Participants will be randomly allocated in a 1:1 ratio to a gamified intervention group or a non-gamified control group. Both groups will complete the same progressive home-based core exercise program for six weeks, with three sessions per week lasting 20-30 minutes. Exercises will include plank, side plank, foot-elevated side plank, dead bug, and bird dog. The intervention group will use a digital app, while the control group will perform the exercises without gamification.

Assessments will be conducted at baseline, week 3, and week 6. Pain intensity will be measured using the Numeric Pain Rating Scale, functional disability using the Oswestry Disability Index, core muscular endurance using trunk flexor, trunk extensor, and side-bridge tests, and adherence as the percentage of completed sessions. The study aims to recruit 60 participants. Data will be analyzed using linear mixed-effects models to compare changes between groups over time. Ethical approval will be obtained before recruitment, and written informed consent will be obtained from all participants.

02

Conditions studied

  • Low Back Pain
  • Low Back Pain and Core Muscle

Browse trials for

Keywords

  • Chronic nonspecific low back pain; Gamification; Core neuromuscular training; Home-based exercise; Functional disability.
03

In context

Low Back Pain

2,875 studies on the registry are indexed under Low Back Pain; 484 are open to participants now.

This study's planned enrollment of 60 is close to the median of 60 across 2,315 interventional studies indexed under Low Back Pain.

Browse Low Back Pain studies →

Lead sponsor

Princess Nourah Bint Abdulrahman University is the lead sponsor of 31 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Female participants aged 18-45 years.
  • Nonspecific low back pain persisting for at least 12 weeks.
  • Baseline pain intensity of ≥3 on the Numeric Pain Rating Scale (NPRS).
  • Ability to perform the prescribed core exercises safely.
  • Ownership of a compatible smartphone.
  • Internet access when required.

Exclusion criteria

Exclusion Criteria:

  • Specific spinal pathology or serious medical conditions.
  • Previous spinal surgery.
  • Neurological symptoms affecting the lower limbs.
  • Pregnancy.
  • Severe musculoskeletal conditions limiting exercise.
  • Current participation in another low back pain rehabilitation program.
  • Any contraindication to exercise.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Arm 1: Gamified Intervention Group

    a six-week home-based core neuromuscular exercise program using a digital application with gamification features.

    Other: Gamified Intervention Group: core neuromuscular exercise program using a digital application with gamification features

  • Active comparator
    Arm 2: Non-Gamified Control Group

    Participants will perform the same six-week home-based core neuromuscular exercise program without gamification, with three sessions per week, each lasting approximately 20-30 minutes.

    Other: Non-Gamified Control Group

Interventions

  • OtherGamified Intervention Group: core neuromuscular exercise program using a digital application with gamification features

    a six-week home-based core neuromuscular exercise program using a digital application with gamification features. The program will include three sessions per week, each lasting approximately 20-30 minutes.

  • OtherNon-Gamified Control Group

    six-week home-based core neuromuscular exercise program without gamification, with three sessions per week, each lasting approximately 20-30 minutes.

06

What researchers measure

Primary outcomes

  1. Change in Pain Intensity

    Pain intensity will be assessed using the Numeric Pain Rating Scale (NPRS), an 11-point scale ranging from 0 (no pain) to 10 (worst imaginable pain). Changes in pain intensity will be compared between the gamified and non-gamified home-based core neuromuscular training groups. Time Frame:

    Time frame: Baseline to Week 6 (6 weeks).

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Nov 2026; primary completion for Feb 2027, 3 months later.

Of 1,187 non-industry interventional studies with no phase under Low Back Pain, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 26. This study's planned 3 months is below that.

Counting every sponsor, half of 1,246 studies reached it within 11 months; a quarter within 5 and three quarters within 26.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 15, 2026
First posted
Oct 22, 2026
StartEst.
Nov 1, 2026
Primary completionEst.
Feb 20, 2027
CompletionEst.
Feb 28, 2027
Last update
Oct 22, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 22, 2026
Show all 1 update
  1. Oct 22, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07890363
Lead sponsor
Princess Nourah Bint Abdulrahman University
Responsible party
Zizi M Ibrahim (Prof . Dr., Princess Nourah Bint Abdulrahman University) — Principal investigator
First posted
Oct 22, 2026
Start date
Nov 1, 2026 (estimated)
Primary completion
Feb 20, 2027 (estimated)
Completion
Feb 28, 2027 (estimated)
Last update
Oct 22, 2026

Study contacts

Zizi M. Ali, Phd
Contact
zmibrahim@pnu.edu.sa
+966118240798

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion